AR095418A1 - Métodos para aumentar el contenido de manosa en proteínas recombinantes - Google Patents
Métodos para aumentar el contenido de manosa en proteínas recombinantesInfo
- Publication number
- AR095418A1 AR095418A1 ARP140100962A ARP140100962A AR095418A1 AR 095418 A1 AR095418 A1 AR 095418A1 AR P140100962 A ARP140100962 A AR P140100962A AR P140100962 A ARP140100962 A AR P140100962A AR 095418 A1 AR095418 A1 AR 095418A1
- Authority
- AR
- Argentina
- Prior art keywords
- manose
- methods
- content
- increase
- recombinant proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Reivindicación 1: Un método para modular una o más especies de glicano de alto contenido de manosa sobre una proteína recombinante durante un proceso de cultivo de células de mamífero caracterizado porque comprende limitar la cantidad de glucosa en el medio de cultivo celular y suplementar el medio de cultivo celular con galactosa o sacarosa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361784639P | 2013-03-14 | 2013-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095418A1 true AR095418A1 (es) | 2015-10-14 |
Family
ID=50397323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100962A AR095418A1 (es) | 2013-03-14 | 2014-03-13 | Métodos para aumentar el contenido de manosa en proteínas recombinantes |
Country Status (17)
Country | Link |
---|---|
US (6) | US9822388B2 (es) |
EP (3) | EP4141104A1 (es) |
AR (1) | AR095418A1 (es) |
CY (1) | CY1120824T1 (es) |
DK (2) | DK3434760T3 (es) |
ES (2) | ES2949507T3 (es) |
FI (1) | FI3434760T3 (es) |
HR (1) | HRP20230667T1 (es) |
HU (2) | HUE063435T2 (es) |
LT (2) | LT2970874T (es) |
PL (2) | PL3434760T3 (es) |
PT (2) | PT3434760T (es) |
RS (1) | RS64326B1 (es) |
SI (2) | SI2970874T1 (es) |
TR (1) | TR201815892T4 (es) |
TW (4) | TWI625390B (es) |
WO (1) | WO2014159259A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI120045B (fi) | 2005-12-22 | 2009-06-15 | Roal Oy | Selluloosamateriaalin käsittely ja siinä käyttökelpoiset entsyymit |
PL2726600T3 (pl) | 2011-07-01 | 2017-08-31 | Amgen Inc. | Hodowla ssaczych komórek |
WO2013114245A1 (en) | 2012-01-30 | 2013-08-08 | Dr. Reddy's Laboratories Limited | Process of modulating man5 and/or afucosylation content of glycoprotein composition |
TWI625390B (zh) | 2013-03-14 | 2018-06-01 | 安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
MX2016005572A (es) * | 2013-10-31 | 2016-12-09 | Amgen Inc | Uso de monensina para regular la glicosilacion de proteinas recombinantes. |
EP3390438A1 (en) * | 2015-12-15 | 2018-10-24 | CSL Behring Recombinant Facility AG | Method for increasing the heterogeneity of o-glycosylation of recombinant factor vii |
EP3585880A1 (en) | 2017-02-27 | 2020-01-01 | Life Technologies Corporation | Expansion of populations of t cells by the use of modified serum free media |
WO2019094333A1 (en) * | 2017-11-13 | 2019-05-16 | Amgen Inc. | Methods for producing protein products |
JP7267284B2 (ja) | 2017-12-20 | 2023-05-01 | アレス トレーディング ソシエテ アノニム | ポリエーテルイオノフォアを使用するタンパク質マンノシル化プロファイルの調節方法 |
KR20210005689A (ko) * | 2018-05-01 | 2021-01-14 | 암젠 인크 | 조절된 글리칸 프로파일을 갖는 항체 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
AU588819B2 (en) | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
AU643427B2 (en) | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
EP1132471A3 (de) | 1989-09-12 | 2001-11-28 | F. Hoffmann-La Roche Ag | TNF-bindende Proteine |
US6204363B1 (en) | 1989-10-16 | 2001-03-20 | Amgen Inc. | Stem cell factor |
US5149792A (en) | 1989-12-19 | 1992-09-22 | Amgen Inc. | Platelet-derived growth factor B chain analogs |
US5272064A (en) | 1989-12-19 | 1993-12-21 | Amgen Inc. | DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
AU651596B2 (en) | 1990-06-05 | 1994-07-28 | Immunex Corporation | Type II interleukin-1 receptors |
PT672141E (pt) | 1992-10-23 | 2003-09-30 | Immunex Corp | Metodos de preparacao de proteinas oligomericas soluveis |
JPH06292592A (ja) * | 1993-02-09 | 1994-10-21 | Snow Brand Milk Prod Co Ltd | 糖蛋白質の生産方法 |
US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US5981713A (en) | 1994-10-13 | 1999-11-09 | Applied Research Systems Ars Holding N.V. | Antibodies to intereleukin-1 antagonists |
JP4435304B2 (ja) | 1995-06-29 | 2010-03-17 | イミュネックス・コーポレーション | アポトーシスを誘導するサイトカイン |
US6613544B1 (en) | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
DE59813187D1 (de) | 1997-12-03 | 2005-12-15 | Roche Diagnostics Gmbh | Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung |
US6337072B1 (en) | 1998-04-03 | 2002-01-08 | Hyseq, Inc. | Interleukin-1 receptor antagonist and recombinant production thereof |
WO2001036637A1 (en) | 1999-11-17 | 2001-05-25 | Immunex Corporation | Receptor activator of nf-kappa b |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
CA2492267C (en) * | 2002-07-15 | 2013-09-10 | Immunex Corporation | Methods and media for controlling sialylation of proteins produced by mammalian cells |
AU2003303394B2 (en) * | 2002-12-23 | 2009-02-19 | Bristol-Myers Squibb Company | Product quality enhancement in mammalian cell culture processes for protein production |
DE102005046225B4 (de) | 2005-09-28 | 2012-01-05 | Cellca Gmbh | Verbessertes Zellkulturmedium |
US20070190057A1 (en) | 2006-01-23 | 2007-08-16 | Jian Wu | Methods for modulating mannose content of recombinant proteins |
CA2757079C (en) | 2009-04-20 | 2015-05-19 | Pfizer Inc. | Control of protein glycosylation and compositions and methods relating thereto |
KR20140032944A (ko) | 2010-10-20 | 2014-03-17 | 모르포테크, 인크. | 항폴레이트 수용체 알파 항체 당형태 |
US9133493B2 (en) | 2011-04-21 | 2015-09-15 | Amgen Inc. | Method for culturing mammalian cells to improve recombinant protein production |
WO2012149197A2 (en) * | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
PL2726600T3 (pl) * | 2011-07-01 | 2017-08-31 | Amgen Inc. | Hodowla ssaczych komórek |
TWI625390B (zh) | 2013-03-14 | 2018-06-01 | 安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
US9481901B2 (en) * | 2013-05-30 | 2016-11-01 | Amgen Inc. | Methods for increasing mannose content of recombinant proteins |
-
2014
- 2014-02-26 TW TW103106527A patent/TWI625390B/zh active
- 2014-02-26 TW TW107106845A patent/TWI720289B/zh active
- 2014-02-26 TW TW110103868A patent/TWI771890B/zh active
- 2014-02-26 TW TW111127240A patent/TWI832345B/zh active
- 2014-03-10 EP EP22179111.4A patent/EP4141104A1/en active Pending
- 2014-03-10 FI FIEP18194714.4T patent/FI3434760T3/fi active
- 2014-03-10 TR TR2018/15892T patent/TR201815892T4/tr unknown
- 2014-03-10 WO PCT/US2014/022738 patent/WO2014159259A1/en active Application Filing
- 2014-03-10 PL PL18194714.4T patent/PL3434760T3/pl unknown
- 2014-03-10 PL PL14714521T patent/PL2970874T3/pl unknown
- 2014-03-10 ES ES18194714T patent/ES2949507T3/es active Active
- 2014-03-10 SI SI201430921T patent/SI2970874T1/sl unknown
- 2014-03-10 PT PT181947144T patent/PT3434760T/pt unknown
- 2014-03-10 PT PT14714521T patent/PT2970874T/pt unknown
- 2014-03-10 ES ES14714521.3T patent/ES2691801T3/es active Active
- 2014-03-10 HR HRP20230667TT patent/HRP20230667T1/hr unknown
- 2014-03-10 LT LTEP14714521.3T patent/LT2970874T/lt unknown
- 2014-03-10 DK DK18194714.4T patent/DK3434760T3/da active
- 2014-03-10 DK DK14714521.3T patent/DK2970874T3/en active
- 2014-03-10 LT LTEP18194714.4T patent/LT3434760T/lt unknown
- 2014-03-10 SI SI201431965T patent/SI3434760T1/sl unknown
- 2014-03-10 US US14/776,404 patent/US9822388B2/en active Active
- 2014-03-10 EP EP18194714.4A patent/EP3434760B1/en active Active
- 2014-03-10 HU HUE18194714A patent/HUE063435T2/hu unknown
- 2014-03-10 HU HUE14714521A patent/HUE040682T2/hu unknown
- 2014-03-10 RS RS20230511A patent/RS64326B1/sr unknown
- 2014-03-10 EP EP14714521.3A patent/EP2970874B1/en active Active
- 2014-03-13 AR ARP140100962A patent/AR095418A1/es unknown
-
2017
- 2017-07-17 US US15/652,138 patent/US20180002733A1/en not_active Abandoned
-
2018
- 2018-11-06 CY CY181101159T patent/CY1120824T1/el unknown
-
2019
- 2019-10-16 US US16/654,933 patent/US11319568B2/en active Active
-
2021
- 2021-12-17 US US17/554,836 patent/US11459595B2/en active Active
-
2022
- 2022-03-25 US US17/704,662 patent/US20220213522A1/en active Pending
-
2023
- 2023-02-22 US US18/172,670 patent/US11952605B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR095418A1 (es) | Métodos para aumentar el contenido de manosa en proteínas recombinantes | |
AR124871A2 (es) | Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes | |
MX2022003994A (es) | Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion dise?ada. | |
CY1125392T1 (el) | Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων | |
TR201900776T4 (tr) | Memeli hücre kültürlerinin hasadına ilişkin yöntem. | |
EA201690529A1 (ru) | Способы модификации клетки-хозяина | |
MX2020011334A (es) | Cultivo celular metabolicamente optimizado. | |
WO2016022377A3 (en) | Methods for modulating the glycosylation profile of recombinant proteins using dissolved oxygen | |
EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
BR112014018630A2 (pt) | alvejamento de glicanos de sulfato de condroitina | |
AR094375A1 (es) | Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular | |
MX2019006633A (es) | Formulaciones de anticuerpo. | |
AR092712A1 (es) | Una proteina con actividad cetosa 3-epimerasa | |
ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
BR112015021189A2 (pt) | métodos de banco de células de alta densidade | |
MX2016005824A (es) | Metodo de cultivo celular. | |
MX2020012356A (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. | |
EA202091349A1 (ru) | Способы культивирования клеток | |
EA202190736A1 (ru) | Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью | |
MY180183A (en) | Methods and compositions for preventing norleucine misincorporation into proteins | |
MX2016011465A (es) | Drimenol-sintasas y metodos para producir drimenol. | |
BR112015019719A2 (pt) | Proteínas melhoradas de ligação ao tnf | |
BR112016015812A2 (pt) | Método para aumentar a biomassa e o conteúdo lipídico em um microrganismo e um microrganismo geneticamente modificado exibindo autofagia reforçada | |
AU2018276376A1 (en) | Cell culture methods | |
MX2016013955A (es) | Drimenol-sintasas y metodo de produccion de drimenol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |